Centessa Pharmaceuticals (CNTA) Other Gross PP&E Adjustments (2022 - 2025)
Centessa Pharmaceuticals (CNTA) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$9.7 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 9.13% to -$9.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$9.7 million, a 9.13% increase, with the full-year FY2024 number at -$11.3 million, up 1.96% from a year prior.
- Other Gross PP&E Adjustments was -$9.7 million for Q3 2025 at Centessa Pharmaceuticals, up from -$10.8 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.3 million in Q2 2022 to a low of -$13.9 million in Q1 2023.
- A 4-year average of -$9.0 million and a median of -$10.8 million in 2025 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 880.5% in 2023, then rose 16.18% in 2024.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments stood at -$2.8 million in 2022, then plummeted by 304.54% to -$11.5 million in 2023, then increased by 1.96% to -$11.3 million in 2024, then rose by 13.45% to -$9.7 million in 2025.
- Per Business Quant, the three most recent readings for CNTA's Other Gross PP&E Adjustments are -$9.7 million (Q3 2025), -$10.8 million (Q2 2025), and -$10.8 million (Q1 2025).